OxTalks is Changing
OxTalks will soon move to the new Halo platform and will become 'Oxford Events.' There will be a need for an OxTalks freeze. This was previously planned for Friday 14th November – a new date will be shared as soon as it is available (full details will be available on the Staff Gateway).
In the meantime, the OxTalks site will remain active and events will continue to be published.
If staff have any questions about the Oxford Events launch, please contact halo@digital.ox.ac.uk
Schizophrenia as a disease of brain energy metabolism: The promise of therapeutic ketosis
Recent evidence suggest that there is a bioenergetics dysfunction characterized by abnormal glucose handling and mitochondrial deficit, in the brain of people with schizophrenia. We identified that ketogenic diet, which provides alternative fuel to glucose for bioenergetic processes in the brain, normalises schizophrenia-like behaviours in translationally relevant pharmacological, genetic and neurodevelopmental mouse models. We have obtained preliminary evidence that the ketogenic substance beta-hydroxybutyrate or faecal microbiota transfer from mice fed with ketogenic diet exert similar beneficial effects in mice maintained on standard diet. This talk will also provide some mechanistic insights on how ketogenic diet/ketosis may exert its therapeutic effect in schizophrenia.
References:
1. Sarnyai, Z., Kraeuter, A.K., Palmer, C. Ketogenic diet for schizophrenia: Clinical implication. Current Opinion in Psychiatry 2019 Sep;32(5):394-401.
2. Kraeuter, AK, van den Buuse, M., Sarnyai, Z. Ketogenic diet and olanzapine treatment alone and in combination reduce a pharmacologically-induced prepulse inhibition deficit in female mice. Schizophrenia Research 2019 Aug 9. pii: S0920-9964(19)30344-5. doi: 10.1016/j.schres.2019.08.002. [Epub ahead of print]
3. Kraeuter, AK, van den Buuse, M, Sarnyai, Z. Ketogenic diet prevents impaired prepulse inhibition of startle in an acute NMDA receptor hypofunction model of schizophrenia. Schizophrenia Research 2019 Apr;206:244-250.
4. Kraeuter, AK, Loxton, H., Costa Lima, B., Rudd, D., Sarnyai, Z. Ketogenic diet reverses behavioral abnormalities in an acute NMDA receptor hypofunction model of schizophrenia. Schizophrenia Res. 2015 Dec;169(1-3):491-3.
Date:
17 October 2019, 14:00
Venue:
Sherrington Building, off Parks Road OX1 3PT
Venue Details:
Large Lecture Theatre
Speaker:
Zoltán Sarnyai, M.D, Ph.D. (Lady Davis Visiting Professor, Technion-Israel Institute of Technology, Haifa, Israel, Professor of Pharmacology, James Cook University, Townsville, Australia )
Organising department:
Department of Physiology, Anatomy and Genetics (DPAG)
Organiser:
Professor Zoltan Molnar (DPAG, University of Oxford)
Organiser contact email address:
zoltan.molnar@dpag.ox.ac.uk
Host:
Professor Zoltan Molnar (DPAG, University of Oxford)
Part of:
Neuroscience Theme Guest Speakers (DPAG)
Booking required?:
Not required
Audience:
Members of the University only
Editor:
Talitha Smith
